Rajesh Rao

Title: Innovations by Rajesh Rao in Pharmaceutical Chemistry

Introduction

Rajesh Rao is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of clopidogrel, a platelet aggregation inhibitor.

Latest Patents

Rajesh Rao holds a patent for "Crystalline polymorphs of clopidogrel." This invention relates to novel crystalline forms of clopidogrel in the form of hydrogen bromide salts, identified as polymorph forms 1, 2, and 3. The patent further details processes for preparing these forms, pharmaceutical compositions comprising them, and their uses. These compositions are particularly useful for inhibiting platelet aggregation and for treating various cardiovascular disorders, including thrombosis and myocardial infarction.

Career Highlights

Rajesh Rao is currently associated with Generics (UK) Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy and safety of medications through the development of new drug formulations.

Collaborations

He has collaborated with notable colleagues such as Ramakrishnan Arul and Ajay Singh Rawat, contributing to a dynamic research environment that fosters innovation.

Conclusion

Rajesh Rao's contributions to pharmaceutical chemistry, particularly through his patent on clopidogrel polymorphs, highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has practical implications for improving patient care.